FDA Adverse Event Injury Summary report: N

GMK-PRIMARY FEMUR STD CEMENTED SIZE 3 R

MDR report key: 18281396 · Received December 7, 2023

Report

Report Number
3005180920-2023-00987
Event Type
Injury
Date Received
December 7, 2023
Date of Event
November 13, 2023
Report Date
December 6, 2023
Manufacturer
MEDACTA INTERNATIONAL SA
Product Code
JWH
UDI-DI
07630040720243
PMA / PMN Number
K173794
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

BATCH REVIEW PERFORMED ON 16-NOV-2023 LOT 111212: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 08-AUG-2011. EXPIRATION DATE: 2016-06-30. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, ALL ITEMS OF THE SAME LOT HAVE BEEN SOLD WITH NO SIMILAR REPORTED CASE DURING THE PERIOD OF THE REVIEW. ADDITIONAL ITEMS INVOLVED IN THE COMPLAINTS, BATCH REVIEW PERFORMED ON 20 NOVEMBER 2023: GMK-PRIMARY 02.07.0217SF TIBIAL INSERT STD FIXED SIZE 2 / 17 MM (K090988) LOT. 101410 LOT 101410: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 09-JUN-2010. EXPIRATION DATE: 2015-04-30. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN SOLD WITH NO SIMILAR REPORTED CASE DURING THE PERIOD OF REVIEW. GMK-PRIMARY 02.07.1202R TIBIAL TRAY FIXED CEMENTED SIZE 2 R (K090988) LOT. 112613 LOT 112613: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 18-OCT-2011. EXPIRATION DATE: 2016-09-30. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, ALL ITEMS OF THE SAME LOT HAVE BEEN SOLD WITH NO SIMILAR REPORTED CASE DURING THE PERIOD OF REVIEW.

Description of Event or Problem · 0

AT ABOUT 11 YEARS AND 9 MONTHS AFTER PRIMARY, THE PATIENT CAME IN REPORTING INSTABILITY DUE TO LAXITY. THE SURGEON REVISED THE GMK PRIMARY FEMORAL COMPONENT, INSERT AND TIBIAL TRAY AND CONVERTED THE PATIENT TO A HINGE KNEE AND THE CASE WAS COMPLETED SUCCESSFULLY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1086028 GMK-PRIMARY FEMUR STD CEMENTED SIZE 3 R CEMENTED FEMUR JWH MEDACTA INTERNATIONAL SA 111212 07630040720243

Patients

Seq Age Sex Outcome Treatment
1 Female Required Intervention